SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001358403-19-000020
Filing Date
2019-02-05
Accepted
2019-02-05 16:09:39
Documents
2
Period of Report
2019-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_154940096536489.html 4  
1 FORM 4 wf-form4_154940096536489.xml 4 4048
2 POWER OF ATTORNEY poa-shaneward.htm EX-24 3317
  Complete submission text file 0001358403-19-000020.txt   8857
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERSARTIS, INC. 4200 BOHANNON DR., SUITE 250 MENLO PARK CA 94025
Business Address
Ward Shane (Reporting) CIK: 0001638380 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 19567968